HIGHLIGHTS   |  January 11, 2020   Risks Associated with Self-Management of Opioids in Outpatient Setting of Cancer Treatment Researchers found that patients in this study used a number of unsafe practices to limit opioid use, including turning to other substances to avoid “harder medicines.” Read more   FDA Approves Pembrolizumab for Treatment of Certain Patients with NMIBC The FDA approved pembrolizumab for the treatment of patients with BCG–unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in-situ with or without papillary tumors who are ineligible for or chose to not undergo cystectomy. Read more   In Case You Missed It   Madelaine Kuiper, MSN, NP, Discusses Rapid Development of HER2-Targeted Therapies The nurse practitioner from UCLA Health spoke about the expanding treatment options in this setting. Read more